© Copyright 2001-2023 Erowid Center. DrugsData is a project of
Erowid Center. All rights reserved.
By using this site you agree not to publish its images, data, results, or analysis of its results without written permission from Erowid Center.
Permission is required before using data from DrugsData in any of these ways, including importing it into public or shared databases, software, or systems.
This policy has been in place since 2001 in order to require cooperation and credit by researchers and app authors.
Your javascript is turned off.
To remove this message, turn on javascript and accept the Terms of Use.
Trace ketamine is likely the result of tablet brushing against a speck of ketamine before arriving at the lab. It is unlikely that the tablet contained psychoactive amounts of ketamine.
Sender describes sample as 'New-to-the-scene designer drug being marketed as 'unicorn' -- molecular makeup/components unknown.'
Ecstasy/Molly tablets must be whole tablets, partial tablets are not eligible for the same co-pay.
If you know whether anybody ingested a tablet like this and experienced effects, please let us know!